Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PIK-93 is an inhibitor of phosphatidylinositol 4-kinase IIIβ (PI4KIIIβ; IC50 = 19 nM).1 It is selective for PI4KIIIβ over PI4KIIIα and PI4KIIα (IC50s = 1,100 and >100,000 nM, respectively). However, it also inhibits the PI3K catalytic subunits (IC50s = 39, 590, 120, and 16 nM for p110α, p110β, p110δ, and p110γ, respectively). PIK-93 reduces enteroviral RNA replication when used at a concentration of 125 nM in HeLa cells.2 It also inhibits the transport of ceramide from the endoplasmic reticulum to the Golgi apparatus.3
WARNING This product is not for human or veterinary use.
1. A pharmacological map of the PI3-
2. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141(5), 799-811 (2010).
3. Phosphatidylinositol 4-
A global lipid map defines a network essential for Zika virus replication. Nat. Commun. 11(1), 3652 (2020).